Author

Jeanne A. Stuckey

University of MichiganORCID 0000-0002-4192-8900Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Amanda L. GarneriD· 1 shared Andrew P. LiebermaniD· 1 shared Arya MenoniD· 1 shared David B. LombardiD· 1 shared Elyse M. Petrunak· 1 shared Emilio L. Cárdenas· 1 shared Fathiya M. Al-Murshedi· 1 shared Gabriela Vega-Hernández· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Amanda L. GarnerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Second-Generation Cap Analogue Prodrugs for Targeting Aberrant Eukaryotic Translation Initiation Factor 4E (eIF4E) Activity in Drug-Resistant Melanoma

Emilio L. Cárdenas, Rachel L. O’Rourke, Arya Menon, Gabriela Vega-Hernández, Jennifer L. Meagher, Jeanne A. Stuckey, Amanda L. Garner

This study develops second-generation cap analogue inhibitors to target eIF4E-mediated cap-dependent translation in drug-resistant melanoma cells.

bioRxiv · Sep 25, 2024 · PreprintCancer Biology

SIRT5 variants from patients with mitochondrial disease are associated with reduced SIRT5 stability and activity, but not with neuropathology

Taolin Yuan, Surinder Kumar, Mary E. Skinner, Ryan Victor-Joseph, Majd Abuaita, Jaap Keijer, Jessica Zhang, Thaddeus J. Kunkel, Yanghan Liu, Elyse M. Petrunak, Thomas L. Saunders, Andrew P. Lieberman, Jeanne A. Stuckey, Nouri Neamati, Fathiya M. Al-Murshedi, , David B. Lombard

The paper identifies two SIRT5 variants in mitochondrial disease patients that reduce protein stability and activity but not neuropathology, using biochemical and mouse model analyses.

bioRxiv · Dec 6, 2023 · PreprintGenetics